Abstract
In people with cystic fibrosis (pwCF), Pseudomonas aeruginosa (Pa) respiratory infection can be classified as initial, intermittent and chronic, depending on persistence of Pa in consecutive respiratory samples. Inhaled antibiotics such as nebulised levofloxacin (LVX) are used to treat chronic Pa infection. This study determined if Pa isolates from different infection stages differed in ability to adapt in vitro to LVX.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
